ORIGINAL RESEARCH article
Front. Cell. Infect. Microbiol.
Sec. Antibiotic Resistance and New Antimicrobial drugs
Population structure reveals clade-and region-specific dissemination of macrolide-resistant Mycoplasma pneumoniae
- TY
Takeshi Yamamoto 1
- MO
Miki Okuno 1
- YH
Yuki HOSHIKO 2,1
- SI
Shunsuke Iriguchi 1
- YO
Yoshitoshi Ogura 1
- TO
Tomohiro Oishi 3
1. Kurume Daigaku Igakubu, Kurume, Japan
2. Kitasato Daigaku, Minato City, Japan
3. Kawasaki Ika Daigaku, Kurashiki, Japan
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Abstract
Objectives Macrolide-resistant Mycoplasma pneumoniae (MRMP) has become highly prevalent in East Asia since the early 2000s, whereas its prevalence remains relatively low in many other regions. This striking geographic disparity has often been attributed to the expansion of a limited number of resistant lineages. However, the population-structural basis of this regional pattern remains incompletely understood. To address this, we analyzed whole-genome sequences of 613 M. pneumoniae strains, including 86 strains isolated in Japan and 527 publicly available genomes, to investigate the relationships among phylogenetic structure, geographic distribution, and macrolide resistance. Results Macrolide resistance was identified in 61.5% (377/613) of strains, and 94.2% of resistant strains carried the A2063G mutation in the 23S rRNA gene. Resistant strains were strongly concentrated in East Asia (70.5% vs 13.4% in non–East Asian regions), with resistance rates varying across countries, ranging from 30.4% in Japan to 99.0% in China. This pattern cannot be fully explained by the expansion of the well-characterized resistant clade T1-3R alone but is instead likely due to the emergence of resistance in multiple genetic backgrounds. Notably, in T1-2 and T2-2, resistance rates among East Asian strains were 66.0% and 45.4%, respectively, whereas no resistant strains were identified in non–East Asian populations, highlighting regional disparities within the same clonal backgrounds. Phylogenetic network analysis of these clades further suggested that resistant variants did not arise sporadically but emerged through mutation acquisition followed by regional clonal expansion. In contrast to the geographically restricted expansion of resistant clones, macrolide-susceptible strains from different regions occasionally showed close genetic relatedness within 10 SNPs, suggesting that cross-regional dissemination of M. pneumoniae strains can occur. Conclusions These findings suggest that the high prevalence of MRMP in East Asia cannot be explained solely by the expansion of a single resistant lineage. Instead, multiple resistant clones appear to have independently emerged and expanded within several clades that are prevalent in East Asia. This population-structured view of MRMP dissemination provides a framework for understanding regional differences in resistance dynamics and underscores the importance of continued genome-based surveillance to monitor the emergence and regional spread of resistant clones.
Summary
Keywords
Clonal expansion, macrolide resistance, Mycoplasma pneumoniae, phylogenetic analysis, population structure
Received
26 May 2026
Accepted
10 July 2026
Copyright
© 2026 Yamamoto, Okuno, HOSHIKO, Iriguchi, Ogura and Oishi. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Takeshi Yamamoto
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.